IFNA1 and systemic lupus erythematosus: The importance of type I IFNs in the pathogenesis of human autoimmune connective tissue diseases such as SLE is now generally accepted based on genetic and gene expression data and positive phase III clinical trials of IFN-blocking therapy46.